Nanotechnology has transformed the oncology sector by particularly targeting cancer cells
and enhancing the efficacy of conventional therapies, not only improving efficacy of …

The present research aims to develop a series of biodegradable, sustainable and
biocompatible, polyurethanes (PU–S1 to PU-S4). The synthesis of these polyurethanes …

Cancer vaccines have garnered attention as a potential treatment for cancer metastases.
Nevertheless, the clinical response rate to vaccines remains< 30%. Nanoparticles stabilize …

The complex tumor immune pathology requires a precise spatial‐control release of the
combination drugs, but most multi‐drug loaded nanoparticles release all drugs …

Multidrug resistance (MDR) is a major obstacle limiting the effectiveness of chemotherapy
against cancer. The combination strategy of chemotherapeutic agents and siRNA targeting …

Proteolysis‐targeting chimeras (PROTACs) have accelerated drug development; however,
some challenges still exist owing to their lack of tumor selectivity and on‐demand protein …

Cascade-enzyme reaction systems have emerged as promising tools for treating malignant
tumors by efficiently converting nutrients into toxic substances. However, the challenges of …

Despite recent advances in immunotherapy, its efficacy remains constrained by the absence
of immune coordination. Especially, the interplay between tumor‐draining lymph nodes …

In recent years, in situ cancer vaccines, as an emerging cancer immunotherapy strategy,
have garnered considerable attention. This review comprehensively discusses the research …

Constructing precise delivery systems to enhance the antitumor efficacy of drugs represents
a pressing clinical practice need. The characteristics of suitable physiological stability …